Grove Bank & Trust increased its holdings in Intuitive Surgical by 129.4% in Q4, owning 2,936 shares worth $1.66 million. Intuitive Surgical recently reported better-than-expected earnings and revenue growth, supporting its long-term growth outlook despite some regulatory and technical challenges. Analysts remain mostly positive, with a consensus price target around $615, though some caution exists due to FDA safety concerns and recent insider stock sales. The company continues to lead in robotic-assisted surgical systems with strong fundamentals but faces near-term risks from product safety and cybersecurity issues.
In Q2 2026, AMD's stock surged 182.4%, driven by growth in AI workloads linked to large language models. CrowdStrike also saw strong gains of 95.6% due to a positive shift in the AI investment narrative. Conversely, Netflix's stock declined after bea...
The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...
